MetLife (MET) Tops Q3 EPS by 14c
Tweet
Share
E-mail
Get Alerts MET Hot Sheet
Price: $97.62 --0%
Revenue Growth %: +15.8%
Financial Fact:
Other net investment gains (losses): 271M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +15.8%
Financial Fact:
Other net investment gains (losses): 271M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
MetLife (NYSE: MET) reported Q3 EPS of $1.28, $0.14 better than the analyst estimate of $1.14. Revenue for the quarter came in at $17.7 billion versus the consensus estimate of $17.18 billion.
For earnings history and earnings-related data on MetLife (MET) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi turns more bullish on trucking stocks
- BMS myeloma CAR T therapy meets primary endpoint in phase 2 trial
- QNB Corp. sells $254M in securities in portfolio repositioning
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
